Biosensors & POCT– category –
-
AI-Native Biosensors Fuel Precision Drug Delivery: Trinity Biotech and Latch Medical Target Diabetes, Obesity
GlobeNewswire (Trinity Biotech) Ireland Overview Trinity Biotech and Latch Medical have formed a strategic partnership to revolutionize diabetes and obesity treatment. The collaboration integrates Trinity Biotech's AI-native CGM+ wearabl... -
Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics
24-7PressRelease.com (Creative Biolabs) USA Overview Creative Biolabs announced the expansion of its development platform, integrating advanced chip-based microfluidics with electrochemical biosensors to accelerate next-generation Point-... -
RT-CGM Reduces Inpatient and Emergency Department Encounters, Cutting Healthcare Costs for Non-Insulin-Treated Type 2 Diabetes Patients
PubMed USA Overview A retrospective study using US administrative claims data reveals that real-time continuous glucose monitoring (RT-CGM) significantly reduces healthcare resource utilization and associated medical costs among non-insu... -
GraphWear Technologies Revolutionizes Diabetes Management with Needle-Free Sweat-Based CGM Wearable
MTEC USA Overview GraphWear Technologies is developing investigational needle-free continuous glucose monitoring (CGM) wearables using nanotechnology-based skin sensors. This wearable patch sensor is designed to continuously measure gluc... -
Shanghai Jiao Tong University Achieves High-Fidelity EMG Robot Control and Character Recognition with Nepenthes-Inspired Stretchable Electronic Skin
EurekAlert! (Shanghai Jiao Tong University Journal Center) China Overview Researchers at Shanghai Jiao Tong University have developed a Nepenthes-inspired Janus e-skin (SPTL), achieving active sweat management, high breathability, and wa... -
Romanian Innovator PRION POCT Accelerates Critical Biomarker Detection with 15-Minute Point-of-Care Devices
MTEC Romania Overview PRION POCT, a Romanian company, is advancing medical diagnostics with point-of-care (POCT) devices that provide rapid, quantitative detection of cardiac and other critical biomarkers from whole-blood samples in just... -
University of Illinois Develops VPodDuo: A Handheld Molecular Diagnostic Device Detecting Pathogens from Zika to Cancer Markers
University of Illinois USA Overview Researchers at the University of Illinois have developed VPodDuo, a handheld molecular diagnostic device enabling point-of-care (POC) testing outside centralized laboratories. This device can accuratel... -
diaTribe.org Recommends 6 Wearable Devices for Diabetes Management, Featuring Apple Watch & Samsung Galaxy Watch Integration
diaTribe.org USA Overview diaTribe.org has highlighted six wearable devices, including Apple Watch, Samsung Galaxy Watch, Google Pixel Watch, and Garmin Watch, that enhance diabetes management. These devices integrate with CGM systems li... -
Iowa State University Develops Graphene Biosensor for Real-time Sub-ppb Pesticide Detection
HALO Science (Iowa State University) USA Overview Researchers at Iowa State University have developed a low-cost, field-deployable graphene-based microfluidic biosensor platform for rapid quantification of pesticide drift and runoff in a... -
Roche Maximizes Clinical Value by Accelerating Emergency and Infectious Disease Diagnostics with POCT Technology
Roche Switzerland Overview Roche emphasizes that Point-of-Care Testing (POCT) maximizes its value in urgent care and infectious disease diagnostics, such as sepsis and COVID-19, by enabling rapid clinical decision-making. Advances in bio...
